From Casetext: Smarter Legal Research

Wyeth v. Levine

Supreme Court of the United States
Jan 18, 2008
552 U.S. 1161 (2008)
Download
PDF
Check
Treatment

Summary

granting petition for writ of certiorari on question of whether FDA drug labeling requirements imposed on manufacturers preempt state law claims premised on the theory that different labeling judgments were needed to make the drugs reasonably safe for use

Summary of this case from Giles v. Wyeth, Inc.
See 4 Summaries

Opinion

No. 06–1249.

2008-01-18

WYETH, petitioner, v. Diana LEVINE.

Case below, ––– Vt. ––––, ––– A.2d ––––.

Petition for writ of certiorari to the Supreme Court of Vermont granted. Brief of petitioner to be filed on or before Monday, February 25, 2008. Brief of respondent to be filed on or before Monday, March 24, 2008. Reply brief, if any, to be filed in accordance with Rule 25.3 of the Rules of this Court.

Summaries of

Wyeth v. Levine

Supreme Court of the United States
Jan 18, 2008
552 U.S. 1161 (2008)

granting petition for writ of certiorari on question of whether FDA drug labeling requirements imposed on manufacturers preempt state law claims premised on the theory that different labeling judgments were needed to make the drugs reasonably safe for use

Summary of this case from Giles v. Wyeth, Inc.

affirming verdict against defendant Wyeth in a pharmaceutical failure-to-warn case, and finding no preemption by the FDCA

Summary of this case from McDarby v. Merck Co., Inc.

noting that, under the 2006 Preeamble, a drug manufacturer can comply with both FDA regulations and duties imposed by state common law.

Summary of this case from Knipe v. Smithkline Beecham

stating that " ruling by [the Supreme Court of the United States] on the preemption issues presented would provide invaluable guidance to the hundreds of federal and state judges now grappling with these claims."

Summary of this case from RIMBERT v. ELI LILLY COMPANY
Case details for

Wyeth v. Levine

Case Details

Full title:WYETH, petitioner, v. Diana LEVINE.

Court:Supreme Court of the United States

Date published: Jan 18, 2008

Citations

552 U.S. 1161 (2008)
128 S. Ct. 1118
169 L. Ed. 2d 845
75 U.S.L.W. 3500

Citing Cases

RIMBERT v. ELI LILLY COMPANY

The primary issue is whether the Court should postpone briefing on Defendant Eli Lilly and Company's Motion…

Lofton v. McNeil Consumer Specialty Pharma

Decedent subsequently developed septicemia and multi-organ system failure, and he died on June 3, 2000. After…

11 Citing Cases